Schäfer H - Search Results

1

Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils.

Wilms H, Rosenstiel P, Romero-Ramos M, Arlt A, Schäfer H, Seegert D, Kahle PJ, Odoy S, Claasen JH, Holzknecht C, Brandenburg LO, Deuschl G, Schreiber S, Kirik D, Lucius R. Wilms H, et al. Among authors: schafer h. Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):897-909. doi: 10.1177/039463200902200405. Int J Immunopathol Pharmacol. 2009. PMID: 20074453 Free article.

2

The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.

Schäfer H, Diebel J, Arlt A, Trauzold A, Schmidt WE. Schäfer H, et al. FEBS Lett. 1998 Oct 2;436(2):139-43. doi: 10.1016/s0014-5793(98)01109-0. FEBS Lett. 1998. PMID: 9781666 Free article.

3

p22/PRG1: a novel early response gene in pancreatic cancer cells regulated by p53 and NF kappa B.

Schmidt WE, Arlt A, Trauzold A, Schäfer H. Schmidt WE, et al. Among authors: schafer h. Ann N Y Acad Sci. 1999 Jun 30;880:147-56. doi: 10.1111/j.1749-6632.1999.tb09517.x. Ann N Y Acad Sci. 1999. PMID: 10415858 No abstract available.

4

The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo.

Schäfer H, Arlt A, Trauzold A, Hünermann-Jansen A, Schmidt WE. Schäfer H, et al. Biochem Biophys Res Commun. 1999 Aug 19;262(1):139-45. doi: 10.1006/bbrc.1999.1131. Biochem Biophys Res Commun. 1999. PMID: 10448082

5

Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells.

Arlt A, Grobe O, Sieke A, Kruse ML, Fölsch UR, Schmidt WE, Schäfer H. Arlt A, et al. Among authors: schafer h. Oncogene. 2001 Jan 4;20(1):69-76. doi: 10.1038/sj.onc.1204061. Oncogene. 2001. PMID: 11244505

6

Functional disruption of IEX-1 expression by concatemeric hammerhead ribozymes alters growth properties of 293 cells.

Grobe O, Arlt A, Ungefroren H, Krupp G, Fölsch UR, Schmidt WE, Schäfer H. Grobe O, et al. Among authors: schafer h. FEBS Lett. 2001 Apr 13;494(3):196-200. doi: 10.1016/s0014-5793(01)02344-4. FEBS Lett. 2001. PMID: 11311240 Free article.

7

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin.

Arlt A, Vorndamm J, Breitenbroich M, Fölsch UR, Kalthoff H, Schmidt WE, Schäfer H. Arlt A, et al. Among authors: schafer h. Oncogene. 2001 Feb 15;20(7):859-68. doi: 10.1038/sj.onc.1204168. Oncogene. 2001. PMID: 11314019

8

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.

Trauzold A, Wermann H, Arlt A, Schütze S, Schäfer H, Oestern S, Röder C, Ungefroren H, Lampe E, Heinrich M, Walczak H, Kalthoff H. Trauzold A, et al. Among authors: schafer h. Oncogene. 2001 Jul 12;20(31):4258-69. doi: 10.1038/sj.onc.1204559. Oncogene. 2001. PMID: 11464292

9

Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.

Arlt A, Vorndamm J, Müerköster S, Yu H, Schmidt WE, Fölsch UR, Schäfer H. Arlt A, et al. Among authors: schafer h. Cancer Res. 2002 Feb 1;62(3):910-6. Cancer Res. 2002. PMID: 11830551

10

NFkappaB-dependent chemoresistance in solid tumors.

Arlt A, Schäfer H. Arlt A, et al. Among authors: schafer h. Int J Clin Pharmacol Ther. 2002 Aug;40(8):336-47. doi: 10.5414/cpp40336. Int J Clin Pharmacol Ther. 2002. PMID: 12467302 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,180 results

Search Page

Filters